Status:
COMPLETED
Surgical Management of Giant Hepatic Hemangioma
Lead Sponsor:
Université de Sousse
Collaborating Sponsors:
Sahloul Hospital of Sousse
Conditions:
Liver Angioma
Eligibility:
All Genders
15-90 years
Brief Summary
Hepatic hemangiomas are the commonest benign mesenchymal lesions of the liver. Most of these lesions are asymptomatic. Giant hepatic hemangiomas (GHH) (\> 10 cm) are often symptomatic and require surg...
Detailed Description
Hepatic hemangiomas are the most common benign tumors of the liver with the incidence of 0.4 to 20% . They are most often discovered incidentally on imaging studies. Typical hemangiomas usually do not...
Eligibility Criteria
Inclusion
- Radiological diagnosis of geant liver hamangioma.
Exclusion
- Radiological diagnosis of liver hemangioma less than 10cm.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 2 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04709718
Start Date
January 1 2008
End Date
January 2 2020
Last Update
January 14 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.